Citicoline, cytidine nucleotides, CDP-Choline
CDP-Choline is a brain reconstituting phospholipid, which has a protective action on the brain, as stimulates its phospholipid production and reduces its free fatty acids levels. It stimulates high choline concentrations in the body and is able to convert itself to uridine. This supplement is used to prevent or treat aging-associated memory or cognition deficiencies.
- Origin: Plant Based, Animal Product, Synthetic
- Source: Eggs, Meat, Fish, Peanuts, Walnuts, Brazil Nuts, Pecan Nut, Almonds, Hazelnut
- Type: Nootropics
- Age Range: Adults, Seniors
- Toxicity: May be toxic in high doses
- Outcomes: Cognitive Function and Brain Health, Memory Enhancer
What are CDP-Choline benefits?
Citicoline, also known as cytidine-choline diphosphate (CDP-choline) is a nootropic. It is a naturally occurring brain chemical. It has been used for several years outside the United States to treat cerebrovascular disorders (those affecting the blood in the brain), including stroke, and has been studied for use in cognitive impairments and dementia. Because of its importance in maintaining good memory, its supplementation has been gaining supporters from all over the world. Check out the test on our website and find out how to take care of your brain health too.
Table of relations
Outcome
Sub-Outcome
Consistent effects
Strength of effects
Scientific articles
CDP-Choline and Cognitive Function and Brain Health
Cognitive functions are brain skills divided into: memory, perception, language, executive functions, attention and praxis (ability to perform complex movements). These functions depend on healthy synapses and neurons, which require good overall brain functioning. Supplements can affect cognitive performance directly or indirectly. Direct effects can alter or participate in neurotransmissions and influence the brain's energy metabolism. The indirect effects include hormonal changes that affect the brain, and improvements in cognitive disorders such as anxiety, depression and insomnia.
-
Memory Enhancer
Memory lapses are common, after all, who has never forgotten a name or address? In an age of information bombardment, our brain filters what is or is not important to be stored. With these filters, we have the long and short-term memory, in which our brain divides what will be used frequently and what will not be recurrent, like a computer HD. The first happens to many people and is about forgetting common information such as telephone numbers, while the second reflects the loss of memory of moments in life or names of children. However, for these lapses not to become frequent it is important that there is a preventive care with the memory, thus it is possible to avoid greater damage to the cognitive health of this area.
Table of negative interactions
Drugs
Acetazolamide, Brinzolamide Ophthalmic, Deferasirox, Dichlorphenamide, Dolutegravir, Dorzolamide Ophthalmic, Erdafitinib, Ketorolac, Leflunomide, Methazolamide, Methotrexate, Ramucirumab, Teriflunomide
Foods
Eggs
Related videos about CDP-Choline
Other Nootropics
Alpha-GPC is a choline-containing supplement that is found in a large variety of food products but can be pharmacology activated in high doses as w...
Ver maisGinkgo biloba is a herb used in the Traditional Chinese Medicine, for carrying a combination of phenolic compounds that are important for cognitive...
Ver mais
References
- ^ a b c d Parisi V, et al. Cytidine-5′-diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma. Ophthalmology. (1999)
- ^ [No authors listed. Citicoline. Monograph. Altern Med Rev. (2008)
- ^ Bracken BK, et al. Eight weeks of citicoline treatment does not perturb sleep/wake cycles in cocaine-dependent adults. Pharmacol Biochem Behav. (2011)
- ^ a b c d Sarkar AK, et al. A rapid LC-ESI-MS/MS method for the quantitation of choline, an active metabolite of citicoline: Application to in vivo pharmacokinetic and bioequivalence study in Indian healthy male volunteers. J Pharm Biomed Anal. (2012)
- ^ Gibellini F, Smith TK. The Kennedy pathway–De novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB Life. (2010)
- ^ Vance JE, Vance DE. Phospholipid biosynthesis in mammalian cells. Biochem Cell Biol. (2004)
- ^ a b c d Fagone P, Jackowski S. Phosphatidylcholine and the CDP-choline cycle. Biochim Biophys Acta. (2013)
- ^ Aoyama C, Liao H, Ishidate K. Structure and function of choline kinase isoforms in mammalian cells. Prog Lipid Res. (2004)
- ^ Wu G, Vance DE. Choline kinase and its function. Biochem Cell Biol. (2010)
- ^ Jansen SM, et al. Biosynthesis of phosphatidylcholine from a phosphocholine precursor pool derived from the late endosomal/lysosomal degradation of sphingomyelin. J Biol Chem. (2001)
- ^ Jackowski S, Fagone P. CTP: Phosphocholine cytidylyltransferase: paving the way from gene to membrane. J Biol Chem. (2005)
- ^ Cornell RB, Northwood IC. Regulation of CTP:phosphocholine cytidylyltransferase by amphitropism and relocalization. Trends Biochem Sci. (2000)
- ^ Kent C. Regulatory enzymes of phosphatidylcholine biosynthesis: a personal perspective. Biochim Biophys Acta. (2005)
- ^ Cornell RB. Cholinephosphotransferase from mammalian sources. Methods Enzymol. (1992)
- ^ The enzymatic formation of lecithin from cytidine diphosphate choline and D-1,2-diglyceride.
- ^ Henneberry AL, Wistow G, McMaster CR. Cloning, genomic organization, and characterization of a human cholinephosphotransferase. J Biol Chem. (2000)
- ^ Henneberry AL, McMaster CR. Cloning and expression of a human choline/ethanolaminephosphotransferase: synthesis of phosphatidylcholine and phosphatidylethanolamine. Biochem J. (1999)
- ^ Horibata Y, Hirabayashi Y. Identification and characterization of human ethanolaminephosphotransferase1. J Lipid Res. (2007)
- ^ a b c d e Wurtman RJ, et al. Effect of oral CDP-choline on plasma choline and uridine levels in humans. Biochem Pharmacol. (2000)
- ^ a b Lopez G-Coviella I, et al. Metabolism of cytidine (5?)-diphosphocholine (cdp-choline) following oral and intravenous administration to the human and the rat. Neurochem Int. (1987)
- ^ Galletti P, et al. Biochemical rationale for the use of CDPcholine in traumatic brain injury: pharmacokinetics of the orally administered drug. J Neurol Sci. (1991)
- ^ Weiss GB. Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline. Life Sci. (1995)
- ^ a b c Cansev M. Uridine and cytidine in the brain: their transport and utilization. Brain Res Rev. (2006)
- ^ Vásquez JV, Pinardi G. Vasomotor responses in the isolated perfused external and internal carotid vascular beds of the rat. Gen Pharmacol. (1992)
- ^ Edvinsson L, et al. Cholinergic mechanisms in pial vessels. Histochemistry, electron microscopy and pharmacology. Z Zellforsch Mikrosk Anat. (1972)
- ^ Iwayama T, Furness JB, Burnstock G. Dual adrenergic and cholinergic innervation of the cerebral arteries of the rat. An ultrastructural study. Circ Res. (1970)
- ^ Pinardi G, et al. Effects of CDP-choline on acetylcholine-induced relaxation of the perfused carotid vascular beds of the rat. Gen Pharmacol. (1994)
- ^ López-Coviella I, et al. Evidence that 5′-cytidinediphosphocholine can affect brain phospholipid composition by increasing choline and cytidine plasma levels. J Neurochem. (1995)
- ^ a b Cansev M, et al. Cardiovascular effects of CDP-choline and its metabolites: involvement of peripheral autonomic nervous system. Eur J Pharmacol. (2007)
- ^ a b Jochem J, et al. Involvement of the histaminergic system in cytidine 5′-diphosphocholine-induced reversal of critical haemorrhagic hypotension in rats. J Physiol Pharmacol. (2010)
- ^ a b Savci V, et al. Intravenously injected CDP-choline increases blood pressure and reverses hypotension in haemorrhagic shock: effect is mediated by central cholinergic activation. Eur J Pharmacol. (2003)
- ^ a b Savci V, et al. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system. Naunyn Schmiedebergs Arch Pharmacol. (2002)
- ^ a b c Alvarez XA, et al. Citicoline improves memory performance in elderly subjects. Methods Find Exp Clin Pharmacol. (1997)
- ^ Silveri MM, et al. Citicoline enhances frontal lobe bioenergetics as measured by phosphorus magnetic resonance spectroscopy. NMR Biomed. (2008)
- ^ Killgore WD, et al. Citicoline affects appetite and cortico-limbic responses to images of high-calorie foods. Int J Eat Disord. (2010)
- ^ a b Improved Attentional Performance Following Citicoline Administration in Healthy Adult Women.
- ^ Rowley TJ, et al. Antinociceptive and anti-inflammatory effects of choline in a mouse model of postoperative pain. Br J Anaesth. (2010)
- ^ Yaksh TL, Dirksen R, Harty GJ. Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat. Eur J Pharmacol. (1985)
- ^ Gurun MS, et al. The effect of peripherally administered CDP-choline in an acute inflammatory pain model: the role of alpha7 nicotinic acetylcholine receptor. Anesth Analg. (2009)
- ^ a b c Hamurtekin E, Gurun MS. The antinociceptive effects of centrally administered CDP-choline on acute pain models in rats: the involvement of cholinergic system. Brain Res. (2006)
- ^ a b c Bagdas D, et al. The antihyperalgesic effect of cytidine-5′-diphosphate-choline in neuropathic and inflammatory pain models. Behav Pharmacol. (2011)
- ^ Alkondon M, et al. Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons. Eur J Neurosci. (1997)
- ^ Bartolini A, et al. Role of muscarinic receptor subtypes in central antinociception. Br J Pharmacol. (1992)
- ^ Houdi AA, et al. Nicotine-induced alteration in Tyr-Gly-Gly and Met-enkephalin in discrete brain nuclei reflects altered enkephalin neuron activity. Peptides. (1991)
- ^ Zarrindast MR, Pazouki M, Nassiri-Rad S. Involvement of cholinergic and opioid receptor mechanisms in nicotine-induced antinociception. Pharmacol Toxicol. (1997)
- ^ Zarrindast MR, Nami AB, Farzin D. Nicotine potentiates morphine antinociception: a possible cholinergic mechanism. Eur Neuropsychopharmacol. (1996)
- ^ a b c d Hamurtekin E, Bagdas D, Gurun MS. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats. Neurosci Lett. (2007)
- ^ Adibhatla RM, Hatcher JF, Dempsey RJ. Citicoline: neuroprotective mechanisms in cerebral ischemia. J Neurochem. (2002)
- ^ a b Plataras C, Tsakiris S, Angelogianni P. Effect of CDP-choline on brain acetylcholinesterase and Na(+), K(+)-ATPase in adult rats. Clin Biochem. (2000)
- ^ Rao AM, Hatcher JF, Dempsey RJ. Lipid alterations in transient forebrain ischemia: possible new mechanisms of CDP-choline neuroprotection. J Neurochem. (2000)
- ^ Dorman RV, Dabrowiecki Z, Horrocks LA. Effects of CDPcholine and CDPethanolamine on the alterations in rat brain lipid metabolism induced by global ischemia. J Neurochem. (1983)
- ^ Adibhatla RM, Hatcher JF, Dempsey RJ. Effects of citicoline on phospholipid and glutathione levels in transient cerebral ischemia. Stroke. (2001)
- ^ a b Krupinski J, et al. CDP-choline reduces pro-caspase and cleaved caspase-3 expression, nuclear DNA fragmentation, and specific PARP-cleaved products of caspase activation following middle cerebral artery occlusion in the rat. Neuropharmacology. (2002)
- ^ a b Gutiérrez-Fernández M, et al. CDP-choline treatment induces brain plasticity markers expression in experimental animal stroke. Neurochem Int. (2012)
- ^ Sahin S, et al. Effects of citicoline used alone and in combination with mild hypothermia on apoptosis induced by focal cerebral ischemia in rats. J Clin Neurosci. (2010)
- ^ Andersen M, et al. Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model. Stroke. (1999)
- ^ Alonso de Leciñana M, et al. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke. J Neurol Sci. (2006)
- ^ Schäbitz WR, et al. The effects of prolonged treatment with citicoline in temporary experimental focal ischemia. J Neurol Sci. (1996)
- ^ Schäbitz WR, et al. Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia. Stroke. (1999)
- ^ a b Hurtado O, et al. Citicoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke. J Neurochem. (2013)
- ^ a b Dixon CE, Ma X, Marion DW. Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release. J Neurotrauma. (1997)
- ^ Zafonte RD, et al. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA. (2012)
- ^ Dávalos A, et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke. (2002)
- ^ Saver JL. Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair. Rev Neurol Dis. (2008)
- ^ Dávalos A, et al. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet. (2012)
- ^ Amenta F, Tayebati SK. Pathways of acetylcholine synthesis, transport and release as targets for treatment of adult-onset cognitive dysfunction. Curr Med Chem. (2008)
- ^ Wang L, Albrecht MA, Wurtman RJ. Dietary supplementation with uridine-5′-monophosphate (UMP), a membrane phosphatide precursor, increases acetylcholine level and release in striatum of aged rat. Brain Res. (2007)
- ^ Tayebati SK, et al. Effect of choline-containing phospholipids on brain cholinergic transporters in the rat. J Neurol Sci. (2011)
- ^ Tomassoni D, et al. Effects of cholinergic enhancing drugs on cholinergic transporters in the brain and peripheral blood lymphocytes of spontaneously hypertensive rats. Curr Alzheimer Res. (2012)
- ^ a b c Giménez R, Raïch J, Aguilar J. Changes in brain striatum dopamine and acetylcholine receptors induced by chronic CDP-choline treatment of aging mice. Br J Pharmacol. (1991)
- ^ a b Ilcol YO, et al. Intraperitoneal administration of choline increases serum glucose in rat: involvement of the sympathoadrenal system. Horm Metab Res. (2002)
- ^ a b Ilcol YO, et al. Intraperitoneal administration of CDP-choline and its cholinergic and pyrimidinergic metabolites induce hyperglycemia in rats: involvement of the sympathoadrenal system. Arch Physiol Biochem. (2007)
- ^ Cansev M, et al. Peripheral administration of CDP-choline, phosphocholine or choline increases plasma adrenaline and noradrenaline concentrations. Auton Autacoid Pharmacol. (2008)
- ^ Saligaut C, et al. Effects of hypoxia and cytidine (5′) diphosphocholine on the concentrations of dopamine, norepinephrine and metabolites in rat hypothalamus and striatum. Arch Int Pharmacodyn Ther. (1987)
- ^ a b c d Tayebati SK, et al. Modulation of monoaminergic transporters by choline-containing phospholipids in rat brain. CNS Neurol Disord Drug Targets. (2013)
- ^ Mechanism of action of CDP-choline in parkinsonism.
- ^ Wang L, et al. Dietary uridine-5′-monophosphate supplementation increases potassium-evoked dopamine release and promotes neurite outgrowth in aged rats. J Mol Neurosci. (2005)
- ^ a b c Agut J, Ortiz JA, Wurtman RJ. Cytidine (5′)diphosphocholine modulates dopamine K(+)-evoked release in striatum measured by microdialysis. Ann N Y Acad Sci. (2000)
- ^ a b c d Shibuya M, et al. Effects of CDP-choline on striatal dopamine level and behavior in rats. Jpn J Pharmacol. (1981)
- ^ Dusseau JW, Hutchins PM. Stimulation of arteriolar number by salbutamol in spontaneously hypertensive rats. Am J Physiol. (1979)
- ^ Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis.
- ^ Radad K, et al. CDP-choline reduces dopaminergic cell loss induced by MPP(+) and glutamate in primary mesencephalic cell culture. Int J Neurosci. (2007)
- ^ Barrachina M, et al. Neuroprotective effect of citicoline in 6-hydroxydopamine-lesioned rats and in 6-hydroxydopamine-treated SH-SY5Y human neuroblastoma cells. J Neurol Sci. (2003)
- ^ Pulvirenti L, Koob GF. Dopamine receptor agonists, partial agonists and psychostimulant addiction. Trends Pharmacol Sci. (1994)
- ^ Walsh SL, et al. Fluoxetine alters the effects of intravenous cocaine in humans. J Clin Psychopharmacol. (1994)
- ^ Renshaw PF, et al. Short-term treatment with citicoline (CDP-choline) attenuates some measures of craving in cocaine-dependent subjects: a preliminary report. Psychopharmacology (Berl). (1999)
- ^ Brown ES, Gorman AR, Hynan LS. A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence. J Clin Psychopharmacol. (2007)
- ^ Licata SC, et al. Effects of daily treatment with citicoline: a double-blind, placebo-controlled study in cocaine-dependent volunteers. J Addict Med. (2011)
- ^ Lukas SE, et al. Effects of short-term citicoline treatment on acute cocaine intoxication and cardiovascular effects. Psychopharmacology (Berl). (2001)
- ^ a b Teather LA, Wurtman RJ. Dietary cytidine (5′)-diphosphocholine supplementation protects against development of memory deficits in aging rats. Prog Neuropsychopharmacol Biol Psychiatry. (2003)
- ^ Petkov VD, et al. Effect of CDP-choline on learning and memory processes in rodents. Methods Find Exp Clin Pharmacol. (1992)
- ^ a b Mosharrof AH, Petkov VD. Effects of citicholine and of the combination citicholine + piracetam on the memory (experiments on mice). Acta Physiol Pharmacol Bulg. (1990)
- ^ Petkov VD, Mosharrof AH, Petkov VV. Comparative studies on the effects of the nootropic drugs adafenoxate, meclofenoxate and piracetam, and of citicholine on scopolamine-impaired memory, exploratory behavior and physical capabilities (experiments on rats and mice). Acta Physiol Pharmacol Bulg. (1988)
- ^ Gallagher M, Pelleymounter MA. Spatial learning deficits in old rats: a model for memory decline in the aged. Neurobiol Aging. (1988)
- ^ Rapp PR, Rosenberg RA, Gallagher M. An evaluation of spatial information processing in aged rats. Behav Neurosci. (1987)
- ^ Albert M. Neuropsychological and neurophysiological changes in healthy adult humans across the age range. Neurobiol Aging. (1993)
- ^ Rylett RJ, et al. Acetylcholine synthesis and release following continuous intracerebral administration of NGF in adult and aged Fischer-344 rats. J Neurosci. (1993)
- ^ Ando S, et al. Turnover of synaptic membranes: age-related changes and modulation by dietary restriction. J Neurosci Res. (2002)
- ^ Salvador GA, López FM, Giusto NM. Age-related changes in central nervous system phosphatidylserine decarboxylase activity. J Neurosci Res. (2002)
- ^ Teather LA, Wurtman RJ. Chronic administration of UMP ameliorates the impairment of hippocampal-dependent memory in impoverished rats. J Nutr. (2006)
- ^ Mosharrof AH, Petkov VD, Petkov VV. Effects of meclofenoxate and citicholine on learning and memory in aged rats. Acta Physiol Pharmacol Bulg. (1987)
- ^ Spiers PA, et al. Citicoline improves verbal memory in aging. Arch Neurol. (1996)
- ^ Takasaki K, et al. Neuroprotective effects of citidine-5-diphosphocholine on impaired spatial memory in a rat model of cerebrovascular dementia. J Pharmacol Sci. (2011)
- ^ a b Ilcol YO, et al. Choline increases serum insulin in rat when injected intraperitoneally and augments basal and stimulated aceylcholine release from the rat minced pancreas in vitro. Eur J Biochem. (2003)
- ^ Cansev M, et al. Choline, CDP-choline or phosphocholine increases plasma glucagon in rats: involvement of the peripheral autonomic nervous system. Eur J Pharmacol. (2008)
- ^ Rejdak R, et al. Citicoline treatment increases retinal dopamine content in rabbits. Ophthalmic Res. (2002)
- ^ a b Parisi V, et al. Evidence of the neuroprotective role of citicoline in glaucoma patients. Prog Brain Res. (2008)
- ^ a b c d Cavun S, Savci V. CDP-choline increases plasma ACTH and potentiates the stimulated release of GH, TSH and LH: the cholinergic involvement. Fundam Clin Pharmacol. (2004)